XML 26 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY - USD ($)
shares in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2014 $ 736,437,000 $ 346,000 $ 251,541,000 $ 523,949,000 $ (39,399,000)
Beginning Balance, Shares at Dec. 31, 2014   173,084      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock option plans 27,582,000 $ 6,000 27,576,000    
Issuance of common stock under stock option plans, shares   3,040      
Repurchase of common stock (126,351,000) $ 12,000   (126,339,000)  
Repurchase of common stock, shares   (6,412)      
Stock-based compensation expense 21,274,000   21,274,000    
Excess tax benefit from stock option exercises 9,964,000   9,964,000    
Tax benefit for research and development credits as a result of stock options 474,000   474,000    
Payment of dividends (18,062,000)     (18,062,000)  
Net income 187,074,000     187,074,000  
Net unrealized gain (loss) on cash flow hedges, net of tax (27,000)       (27,000)
Reclassification of net realized (gain) loss into current operations 201,000       201,000
Net unrealized gain (loss) on available-for-sale investments, net of tax (939,000)       (939,000)
Reclassification of net realized gain on the sale of available-for-sale investments (344,000)       (344,000)
Foreign currency translation adjustments, net of tax (11,616,000)       (11,616,000)
Balance at Dec. 31, 2015 825,667,000 $ 340,000 310,829,000 566,622,000 (52,124,000)
Balance, Shares at Dec. 31, 2015   169,712      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock option plans 43,468,000 $ 8,000 43,460,000    
Issuance of common stock under stock option plans, shares   3,954      
Repurchase of common stock (47,149,000) $ (4,000)   (47,145,000)  
Repurchase of common stock, shares   (1,788)      
Stock-based compensation expense 20,558,000   20,558,000    
Payment of dividends (25,213,000)     (25,213,000)  
Net income 149,572,000     149,572,000  
Net unrealized gain (loss) on cash flow hedges, net of tax (567,000)       (567,000)
Reclassification of net realized (gain) loss into current operations 398,000       398,000
Net unrealized gain (loss) on available-for-sale investments, net of tax 1,672,000       1,672,000
Reclassification of net realized gain on the sale of available-for-sale investments (191,000)       (191,000)
Foreign currency translation adjustments, net of tax (5,616,000)       (5,616,000)
Balance at Dec. 31, 2016 $ 962,599,000 $ 344,000 374,847,000 643,836,000 (56,428,000)
Balance, Shares at Dec. 31, 2016 84,856 171,878      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock option plans $ 54,557,000 $ 8,000 54,549,000    
Issuance of common stock under stock option plans, shares 4,162 4,162      
Repurchase of common stock $ (123,715,000) $ (5,000)   (123,710,000)  
Repurchase of common stock, shares   (2,533)      
Stock-based compensation expense 31,942,000   31,942,000    
Payment of dividends (29,037,000)     (29,037,000)  
Net income 177,178,000     177,178,000  
Net unrealized gain (loss) on cash flow hedges, net of tax 4,000       4,000
Reclassification of net realized (gain) loss into current operations (41,000)       (41,000)
Net unrealized gain (loss) on available-for-sale investments, net of tax 703,000       703,000
Reclassification of net realized gain on the sale of available-for-sale investments (829,000)       (829,000)
Foreign currency translation adjustments, net of tax 21,992,000       21,992,000
Balance at Dec. 31, 2017 $ 1,095,353,000 $ 347,000 $ 461,338,000 $ 668,267,000 $ (34,599,000)
Balance, Shares at Dec. 31, 2017 85,939 173,507